Category: Corporate NewsBy adminNovember 6, 2023 Author: admin https://ramedapharma-ir.com Post navigationPreviousPrevious post:Disclosure to EGX regarding BOD and shareholding structureNextNext post:Rameda3Q23 BOD Meeting Minutes 13 November 2023Related PostsRameda Announces New Chairman and Additions to its Board of DirectorsJune 3, 2026Rameda Initiates First Acquisition of 2025July 7, 2025Record Dividend Distribution DisclosureJuly 7, 2025Rameda One-Pager 1Q25May 13, 2025Earnings Release One-Pager 4Q24March 10, 2025Earning Release One Pager 3Q24November 14, 2024
